Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer

BACKGROUND: Despite growing therapeutic relevance of ERBB2 amplifications in colorectal cancer (CRC), little is known about ERBB2/ERBB3 mutations. We aimed to characterize these subsets of CRC. METHODS: We performed a retrospective analysis of 419 CRC patients from MD Anderson (MDACC) and 619 patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Cancer Inst
Autori principali: Loree, Jonathan M, Bailey, Ann M, Johnson, Amber M, Yu, Yao, Wu, Wenhui, Bristow, Christopher A, Davis, Jennifer S, Shaw, Kenna R, Broaddus, Russell, Banks, Kimberly C, Lanman, Richard B, Meric-Bernstam, Funda, Overman, Michael J, Kopetz, Scott, Raghav, Kanwal
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292791/
https://ncbi.nlm.nih.gov/pubmed/29718453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy067
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi